Harpagophytum procumbens Root Extract Mediates Anti-Inflammatory Effects in Osteoarthritis Synoviocytes through CB2 Activation
Authors:
- Alessia MarianoAMAlessia Mariano
- Irene BigioniIBIrene Bigioni
- Roberto MattioliRMRoberto Mattioli
- Antonella Di SottoAntonella Di Sotto
- Martina LeopizziMLMartina Leopizzi
- Stefania GarzoliStefania Garzoli
- Pier Francesco MarianiPMPier Francesco Mariani
- Pietro Dalla VedovaPVPietro Dalla Vedova
- Sergio AmmendolaSASergio Ammendola
- Anna Scotto D’abuscoADAnna Scotto D’abusco
Open Access
- 9 April 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (4) , 457
Abstract
The endocannabinoid system is involved in the nociceptive and anti-inflammatory pathways, and a lowered expression of CB2 receptors has been associated with inflammatory conditions, such as osteoarthritis (OA). This suggests that CB2 modulators could be novel therapeutic tools to treat OA. In the present study, the involvement of Harpagophytum procumbens root extract, a common ingredient of nutraceuticals used to treat joint disorders, in CB2 modulation has been evaluated. Moreover, to clarify the effects of the pure single components, the bioactive constituent, harpagoside, and the main volatile compounds were studied alone or in a reconstituted mixture. Human fibroblast-like synoviocytes, extracted by joints of patients, who underwent a total knee replacement, were treated with an H. procumbens root extract dissolved in DMSO (HPEDMSO). The effectiveness of HPEDMSO to affect CB2 pathways was studied by analyzing the modulation of cAMP, the activation of PKA and ERK MAP kinase, and the modulation of MMP-13 production. HPEDMSO was able to inhibit the cAMP production and MAP kinase activation and to down-regulate the MMP-13 production. Pure compounds were less effective than the whole phytocomplex, thus suggesting the involvement of synergistic interactions. Present findings encourage further mechanistic studies and support the scientific basis of the use of H. procumbens in joint disorders.Keywords
This publication has 47 references indexed in Scilit:
- Current nutraceuticals in the management of osteoarthritis: a reviewTherapeutic Advances in Musculoskeletal Disease, 2012
- A peptidyl-glucosamine derivative affects IKKα kinase activity in human chondrocytesArthritis Research & Therapy, 2010
- Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoproteinPhytomedicine, 2009
- Beta-caryophyllene is a dietary cannabinoidProceedings of the National Academy of Sciences, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisArthritis Research & Therapy, 2008
- Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytesArthritis Research & Therapy, 2007
- Anti-inflammatory effects of compounds alpha-humulene and (−)-trans-caryophyllene isolated from the essential oil of Cordia verbenaceaEuropean Journal of Pharmacology, 2007
- Treatment of patients with arthrosis of hip or knee with an aqueous extract of Devil's Claw (Harpagophytum procumbens DC.)Phytotherapy Research, 2003
- Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritisPhytomedicine, 2000